United Therapeut (UTHR)
$290.01
2.45 (0.84%)
UTHR Stock Quote Delayed 30 Minutes
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$307.36
Market Cap
13.80B
PE Ratio
11.77
EPS
24.6393
Volume (Avg. Vol.)
579,460
Day's Range
$290.33 - $308.10
52-Week Range
$230.39 - $417.82
Dividend & Yield
N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeut News
3 Undervalued Stocks on Track to Double (or More) by 2028
The stock market is on the brink of a multi-year bull market. Consider these undervalued growth stocks to buy that can double or more by 2028.
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
The 3 Best Medical Device Stocks to Buy in June 2024
Medical devices are at the forefront of the digitalization of medicine. making these the three best medical device stocks to buy.
UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024
UTHR stock results show that United Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
3 Underappreciated Healthcare Stocks to Buy Now: April 2024
Novo Nordisk (NVO), United Therapeutics (UTHR) and Vertex Pharmaceuticals (VRTX) are three underappreciated healthcare stocks to buy in April.
The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024
Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.
3 Must-Buy Healthcare Stocks for a Healthy 2024
The best healthcare stocks to buy for a healthy 2024 include these 3 companies that have shown stability and growth.
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
